Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69613 publications

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs.

Journal: Cell transplantation
Published: December 16, 2025

Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.

Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.

Journal: BMJ case reports
Published: December 15, 2025

One train can hide another one, a case of myelodysplastic syndrome (MDS) and splenic diffuse red pulp small B cell lymphoma (SDRPL).

One train can hide another one, a case of myelodysplastic syndrome (MDS) and splenic diffuse red pulp small B cell lymphoma (SDRPL).

Journal: Annales de biologie clinique
Published: December 15, 2025

Verification of the protective effect of transfecting brain-derived neurotrophic factor and B-cell lymphoma 2 genes on retina ganglion cells in a rat model of optic nerve injury.

Verification of the protective effect of transfecting brain-derived neurotrophic factor and B-cell lymphoma 2 genes on retina ganglion cells in a rat model of optic nerve injury.

Journal: Drug discoveries & therapeutics
Published: December 14, 2025

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Journal: Expert opinion on biological therapy
Published: December 12, 2025

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2025

Case studies on the role of computerized tomography pulmonary angiography in improving clinical diagnosis of invasive pulmonary aspergillosis.

Case studies on the role of computerized tomography pulmonary angiography in improving clinical diagnosis of invasive pulmonary aspergillosis.

Journal: Future microbiology
Published: December 12, 2025

Correction to "Defining and Addressing the Current Unmet Medical Needs for the Frontline Treatment of Advanced Stage Aggressive Large B-Cell Lymphoma: A Perspective From an Ad Hoc Panel of Italian Experts".

Correction to "Defining and Addressing the Current Unmet Medical Needs for the Frontline Treatment of Advanced Stage Aggressive Large B-Cell Lymphoma: A Perspective From an Ad Hoc Panel of Italian Experts".

Journal: Hematological oncology
Published: December 12, 2025

1α,25(OH) 2D 3 prevents CD19 CAR-T cell exhaustion and differentiation via VDR-dependent transcriptional reprogramming.

1α,25(OH) 2D 3 prevents CD19 CAR-T cell exhaustion and differentiation via VDR-dependent transcriptional reprogramming.

Journal: Acta biochimica et biophysica Sinica
Published: December 11, 2025

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Prebiopsy Steroids and Diagnostic Yield in Patients With Diffuse Large B-Cell Lymphoma.

Journal: JAMA network open
Published: December 11, 2025

Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Bridging the Gap: Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell Lymphoma: Long-Term Benefit, Yet Real-World Complexity.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 10, 2025

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.

Journal: Future oncology (London, England)
Published: December 10, 2025
Showing 1-12 of 69,613

Last Updated: 01/07/2026